Online citations, reference lists, and bibliographies.

Multimorbidity And Survival In Older Persons With Colorectal Cancer.

Cary P Gross, Zhenchao Guo, G J Mcavay, Heather G Allore, Mary Young, Mary Tinetti
Published 2006 · Medicine
Cite This
Download PDF
Analyze on Scholarcy
Share
OBJECTIVES To ascertain the effect of common chronic conditions on mortality in older persons with colorectal cancer. DESIGN Retrospective cohort study. SETTING Population-based cancer registry. PARTICIPANTS Patients in the Surveillance Epidemiology and End Results-Medicare linked database who were aged 67 and older and had a primary diagnosis of Stage 1 to 3 colorectal cancer during 1993 through 1999. MEASUREMENTS Chronic conditions were identified using claims data, and vital status was determined from the Medicare enrollment files. After estimating the adjusted hazard ratios for mortality associated with each condition using a Cox model, the population attributable risk (PAR) was calculated for the full sample and by age subgroup. RESULTS The study sample consisted of 29,733 patients, 88% of whom were white and 55% were female. Approximately 9% of deaths were attributable to congestive heart failure (CHF; PAR = 9.4%, 95% confidence interval (CI) = 8.4-10.5%), more than 5% were attributable to chronic obstructive pulmonary disease (COPD; PAR = 5.3%, 95% CI = 4.7-6.6%), and nearly 4% were attributable to diabetes mellitus (PAR = 3.9%, 95% CI = 3.1-4.8%). The PAR associated with CHF increased with age, from 6.3% (95% CI = 4.4-8.8%) in patients aged 67 to 70 to 14.5% (95% CI = 12.0-17.5%) in patients aged 81 to 85. Multiple conditions were common. More than half of the patients who had CHF also had diabetes mellitus or COPD. The PAR associated with CHF alone (4.29%, 95% CI = 3.68-4.94%) was similar to the PAR for CHF in combination with diabetes mellitus (3.08, 95% CI = 2.60-3.61%) or COPD (3.93, 95% CI = 3.41-4.54%). CONCLUSION A substantial proportion of deaths in older persons with colorectal cancer can be attributed to CHF, diabetes mellitus, and COPD. Multimorbidity is common and exerts a substantial effect on colorectal cancer survival.



This paper is referenced by
Colorectal Cancer ( CRC ) Screening in the Geriatric Population : Factors in Risk Assessment and Outcome Benefits
(2008)
10.1016/j.socscimed.2009.07.040
Do patient characteristics, disease, or treatment explain social inequality in survival from colorectal cancer?
Birgitte Lidegaard Frederiksen (2009)
10.1136/bmjopen-2015-009284
Is referral of postsurgical colorectal cancer survivors to cardiac rehabilitation feasible and acceptable? A pragmatic pilot randomised controlled trial with embedded qualitative study
Gill Hubbard (2016)
10.1186/1471-2407-9-116
The effect of comorbidity on the use of adjuvant chemotherapy and survival from colon cancer: a retrospective cohort study
Diana Sarfati (2008)
10.1111/apt.12667
Pre-admission use of glucocorticoids and 30-day mortality following colorectal cancer surgery: a population-based Danish cohort study.
Eva Bjerre Ostenfeld (2014)
10.6000/1929-6029.2016.05.01.5
Individualized Absolute Risk Calculations for Persons with Multiple Chronic Conditions: Embracing Heterogeneity, Causality, and Competing Events
Heather G Allore (2016)
10.1007/978-981-10-1844-2_2
How Do We Measure Comorbidity
Diana Sarfati (2016)
10.1371/journal.pone.0206915
Using item response theory with health system data to identify latent groups of patients with multiple health conditions
Katherine M Prenovost (2018)
10.1007/s10654-019-00543-0
The major causes and risk factors of total and cause-specific mortality during 5.4-year follow-up: the Shanghai Changfeng Study
Li Wu (2019)
10.1111/jgs.13423
Lumbar pain as unusual presentation of bone marrow metastatic replacement by colon carcinoma.
Cecilia Soavi (2015)
Survival after colorectal cancer in a screened vs unscreened population
Astri Syse (2013)
10.1007/978-3-319-31831-8_26
Evaluation and Management of Older Adults with Multimorbidity and Cancer: A Geriatric Perspective on Oncology Care
Thuy T. Koll (2017)
10.15256/joc.2014.4.41
Competing risks of cancer mortality and cardiovascular events in individuals with multimorbidity
Elizabeth A Bayliss (2014)
New developments in the adjuvant therapy of stage II colon cancer. Risk assessments in the older patient.
Nadine Jackson McCleary (2010)
10.21614/chirurgia.113.2.210
The Outcome of Colorectal Surgery in Cirrhotic Patients: A Case Match Report.
Monica Lăcătuş (2018)
10.1371/journal.pone.0155608
The Evaluation of More Lymph Nodes in Colon Cancer Is Associated with Improved Survival in Patients of All Ages
Wouter B Aan de Stegge (2016)
10.1016/j.dld.2014.05.005
Management of patients over 80 years of age treated with resection for localised colon cancer: results from a French referral centre.
Astrid Lièvre (2014)
10.2147/CLEP.S47154
Comorbidity and survival of Danish patients with colon and rectal cancer from 2000–2011: a population-based cohort study
Eva Bjerre Ostenfeld (2013)
10.1007/s13668-012-0034-y
The Role of Diabetes and Diabetes Treatments in Colorectal Cancer Mortality, Incidence, and Survival
Peter T. Campbell (2012)
10.3310/HSDR04240
The use of cardiac rehabilitation services to aid the recovery of patients with bowel cancer: a pilot randomised controlled trial with embedded feasibility study
Gill Hubbard (2016)
10.5327/z2447-211520161600004
CHEMotHErAPY For ElDErlY PAtiEntS WitH gAStriC CAnCEr: EXPEriEnCE oF A BrAZiliAn CEntEr
Pedro Aguiar (2016)
10.2147/PROM.S49589
Optimal delivery of colorectal cancer follow-up care: improving patient outcomes
Mikaela Jorgensen (2015)
10.1007/s00432-010-0879-7
Diabetes mellitus negatively impacts survival of patients with colon cancer, particularly in stage II disease
Yu-Chung Huang (2010)
10.1007/s00125-013-2917-x
Cause-specific mortality in Scottish patients with colorectal cancer with and without type 2 diabetes (2000–2007)
Julia J. Walker (2013)
10.1007/s12029-012-9455-5
Burden of Emergency and Non-emergency Colorectal Cancer Surgeries in West Virginia and the USA
Neel A. Shah (2012)
10.1016/j.jgo.2014.04.005
Determinants of short- and long-term survival from colorectal cancer in very elderly patients.
J Sheridan (2014)
10.1093/annonc/mds023
Changes in survival by ethnicity of patients with cancer between 1992-1996 and 2002-2006: is the discrepancy decreasing?
Dianne Pulte (2012)
10.1136/pgmj.2009.084566
Does the timing of comorbidity affect colorectal cancer survival? A population based study
Lorraine G Shack (2010)
10.1038/s41598-019-44969-8
The effects of comorbidity on colorectal cancer mortality in an Australian cancer population
Maleshwane Lettie Pule (2019)
Patterns and Prediction of Competing Causes of Mortality in Older Adults Diagnosed with Indolent Non-Hodgkin Lymphoma
Laura L Hester (2017)
10.1111/ajco.12130
Identifying important comorbidity among cancer populations using administrative data: Prevalence and impact on survival.
Diana Sarfati (2016)
10.1007/S12612-011-0172-7
La prise en charge du syndrome confusionnel comme exemple de coopération médicochirurgicale chez la personne âgée présentant un cancer
Tristan Cudennec (2011)
See more
Semantic Scholar Logo Some data provided by SemanticScholar